A Single Oral Dose of Diclofenac Causes Transition of Experimental Subclinical Acute Kidney Injury to Chronic Kidney Disease

MLA

Johanna Störmer, et al. “A Single Oral Dose of Diclofenac Causes Transition of Experimental Subclinical Acute Kidney Injury to Chronic Kidney Disease.” Biomedicines, vol. 10, no. 5, May 2022, p. 1198. EBSCOhost, https://doi.org/10.3390/biomedicines10051198.

APA

Johanna Störmer, Wilfried Gwinner, Katja Derlin, Stephan Immenschuh, Song Rong, Mi-Sun Jang, Nelli Shushakova, Hermann Haller, Faikah Gueler, & Robert Greite. (2022). A Single Oral Dose of Diclofenac Causes Transition of Experimental Subclinical Acute Kidney Injury to Chronic Kidney Disease. Biomedicines, 10(5), 1198. https://doi.org/10.3390/biomedicines10051198

Chicago

Johanna Störmer, Wilfried Gwinner, Katja Derlin, Stephan Immenschuh, Song Rong, Mi-Sun Jang, Nelli Shushakova, Hermann Haller, Faikah Gueler, and Robert Greite. 2022. “A Single Oral Dose of Diclofenac Causes Transition of Experimental Subclinical Acute Kidney Injury to Chronic Kidney Disease.” Biomedicines 10 (5): 1198. doi:10.3390/biomedicines10051198.